Companies
Nomad Bioscience
already holds secured US regulatory approval for Thaumatin II, a natural super-sweet plant-made protein, commercialized through its NAMBAWAN Biotech food-market spin-off, with approvals in other countries pending.
- Country
- Germany
Coverage
| EU | US | |
|---|---|---|
| food-alt-protein | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | No public funding rounds identified for Nambawan Biotech GmbH; capital reported as €25,000 for Nambawan Biotech GmbH and €3,000 for Nambawan Spain SL | datoscif.es · nomadbioscience.com · northdata.com |
| Capacity | Industrial volumes reported as available, supported by agricultural infrastructure in Extremadura, Spain | namba-wan.com · nomadbioscience.com |
| Certification | Working on certifications for diabetic safety, kosher, halal, and vegan standards; no current certifications stated medium confidence | namba-wan.com · nomadbioscience.com |
| Regulatory approval | Thaumatin II holds US GRAS status (FDA and FEMA), as of 2022 | namba-wan.com · nomadbioscience.com |
| Production site | Extremadura, Spain | namba-wan.com · nomadbioscience.com |
| Headcount | Not available | life-sciences-europe.com · nomadbioscience.com |
| Revenue | Not available | nomadbioscience.com |
Independent sources: datoscif.es · life-sciences-europe.com · namba-wan.com · northdata.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Molecular farming for food | food-alt-protein | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.